The approval of esketamine, known as Spravato, for use against severe depression is special -- it is saving lives.
One of General Electric's biggest liabilities will be outlined on Thursday.
Traders could go long on ISRG here, or wait to buy strength.
General Electric's CEO isn't inspiring much confidence.
This is one where many shareholders can no longer take the pain and will sell at all costs.
If we didn't know where the algorithms that now control the point of sale were lined up before Monday, we sure know now.
Are we late to the game with the stock up so much?
Experts offer their top stock ideas in oncology detection and treatment.
Let's see what we can glean from the charts and indicators.
CVS' spending spree has developed a deep debt issue for the company.